Edwards Lifesciences holds $13.3B in total assets. Shareholders' equity is $10.3B against $702.9M in total debt. Cash and equivalents total $2.4B. The current ratio is 4.42 and debt-to-equity is 0.068. Based on the Q1 2026 filing.